

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.43033976 |
| 2 | glutamate secretion (GO:0014047) | 5.71898696 |
| 3 | dicarboxylic acid biosynthetic process (GO:0043650) | 5.65747318 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.27532217 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.27532217 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.18922272 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.85778240 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.85778240 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.82634379 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.81715901 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.73805216 |
| 12 | GDP-mannose metabolic process (GO:0019673) | 4.70231231 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.59910721 |
| 14 | protein retention in ER lumen (GO:0006621) | 4.50405543 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.48890355 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 4.36262260 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 4.36262260 |
| 18 | tryptophan catabolic process (GO:0006569) | 4.36262260 |
| 19 | regulation of cholesterol homeostasis (GO:2000188) | 4.33284430 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.22937589 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.21649999 |
| 22 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.21116481 |
| 23 | tryptophan metabolic process (GO:0006568) | 4.16971803 |
| 24 | glutamate metabolic process (GO:0006536) | 3.98265091 |
| 25 | glyoxylate metabolic process (GO:0046487) | 3.96887302 |
| 26 | reverse cholesterol transport (GO:0043691) | 3.96034210 |
| 27 | negative regulation of cholesterol transport (GO:0032375) | 3.95344066 |
| 28 | negative regulation of sterol transport (GO:0032372) | 3.95344066 |
| 29 | positive regulation of synapse maturation (GO:0090129) | 3.93057680 |
| 30 | proline biosynthetic process (GO:0006561) | 3.91251028 |
| 31 | protein maturation by protein folding (GO:0022417) | 3.86550898 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 3.84900982 |
| 33 | heparin metabolic process (GO:0030202) | 3.81260717 |
| 34 | heparin biosynthetic process (GO:0030210) | 3.81260717 |
| 35 | bile acid biosynthetic process (GO:0006699) | 3.79470375 |
| 36 | regulation of fibrinolysis (GO:0051917) | 3.78206845 |
| 37 | mitotic nuclear envelope reassembly (GO:0007084) | 3.73342789 |
| 38 | nuclear envelope reassembly (GO:0031468) | 3.73342789 |
| 39 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.68808648 |
| 40 | urea cycle (GO:0000050) | 3.67971475 |
| 41 | urea metabolic process (GO:0019627) | 3.67971475 |
| 42 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.66830325 |
| 43 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66800507 |
| 44 | embryonic skeletal joint morphogenesis (GO:0060272) | 3.65804450 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 3.65612001 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 3.65612001 |
| 47 | macromolecular complex remodeling (GO:0034367) | 3.65612001 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.59805863 |
| 49 | phospholipid efflux (GO:0033700) | 3.59115656 |
| 50 | response to gravity (GO:0009629) | 3.58418438 |
| 51 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.57354154 |
| 52 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.54961312 |
| 53 | sulfur amino acid catabolic process (GO:0000098) | 3.53337623 |
| 54 | cellular modified amino acid catabolic process (GO:0042219) | 3.52487907 |
| 55 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.50163822 |
| 56 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.46890703 |
| 57 | protein carboxylation (GO:0018214) | 3.44693071 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.44693071 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 3.43307031 |
| 60 | acylglycerol homeostasis (GO:0055090) | 3.41835707 |
| 61 | triglyceride homeostasis (GO:0070328) | 3.41835707 |
| 62 | plasma lipoprotein particle assembly (GO:0034377) | 3.41640354 |
| 63 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.40318855 |
| 64 | COPI coating of Golgi vesicle (GO:0048205) | 3.39721574 |
| 65 | Golgi transport vesicle coating (GO:0048200) | 3.39721574 |
| 66 | low-density lipoprotein particle remodeling (GO:0034374) | 3.38309906 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 3.36252435 |
| 68 | amine catabolic process (GO:0009310) | 3.36252435 |
| 69 | cerebellar Purkinje cell layer development (GO:0021680) | 3.35926566 |
| 70 | bile acid metabolic process (GO:0008206) | 3.33492767 |
| 71 | tyrosine metabolic process (GO:0006570) | 3.33433777 |
| 72 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.28605762 |
| 73 | regulation of oxidative phosphorylation (GO:0002082) | 3.27930057 |
| 74 | cholesterol efflux (GO:0033344) | 3.26842496 |
| 75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.26712837 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.25586027 |
| 77 | regulation of triglyceride catabolic process (GO:0010896) | 3.25375166 |
| 78 | nitrogen cycle metabolic process (GO:0071941) | 3.23961835 |
| 79 | synaptic vesicle endocytosis (GO:0048488) | 3.23655839 |
| 80 | valine metabolic process (GO:0006573) | 3.22422562 |
| 81 | protein-lipid complex assembly (GO:0065005) | 3.21644243 |
| 82 | aromatic amino acid family metabolic process (GO:0009072) | 3.20415439 |
| 83 | sodium ion export (GO:0071436) | 3.20153068 |
| 84 | serine family amino acid catabolic process (GO:0009071) | 3.19827796 |
| 85 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.16790886 |
| 86 | coenzyme catabolic process (GO:0009109) | 3.16746293 |
| 87 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.15866866 |
| 88 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.15534616 |
| 89 | bile acid and bile salt transport (GO:0015721) | 3.14612852 |
| 90 | neurotransmitter secretion (GO:0007269) | 3.14165772 |
| 91 | cellular potassium ion homeostasis (GO:0030007) | 3.14129518 |
| 92 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.11903417 |
| 93 | cellular amino acid catabolic process (GO:0009063) | 3.10984885 |
| 94 | type B pancreatic cell proliferation (GO:0044342) | 3.10626041 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.09226627 |
| 96 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.09053278 |
| 97 | regulation of protein activation cascade (GO:2000257) | 3.08945457 |
| 98 | plasma lipoprotein particle organization (GO:0071827) | 3.08741026 |
| 99 | positive regulation of histone deacetylation (GO:0031065) | 3.08492233 |
| 100 | regulation of synapse structural plasticity (GO:0051823) | 3.08021491 |
| 101 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.07963226 |
| 102 | indolalkylamine metabolic process (GO:0006586) | 3.06013662 |
| 103 | amino-acid betaine metabolic process (GO:0006577) | 3.04615875 |
| 104 | protein insertion into membrane (GO:0051205) | 3.04289815 |
| 105 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.02189538 |
| 106 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.01549209 |
| 107 | cysteine metabolic process (GO:0006534) | 3.00596077 |
| 108 | complement activation, alternative pathway (GO:0006957) | 2.99918957 |
| 109 | protein-lipid complex subunit organization (GO:0071825) | 2.99252918 |
| 110 | cellular ketone body metabolic process (GO:0046950) | 2.98573106 |
| 111 | ethanol oxidation (GO:0006069) | 2.98256483 |
| 112 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.97963334 |
| 113 | benzene-containing compound metabolic process (GO:0042537) | 2.97681559 |
| 114 | drug catabolic process (GO:0042737) | 2.96464197 |
| 115 | short-chain fatty acid metabolic process (GO:0046459) | 2.96448494 |
| 116 | regulation of synaptic vesicle transport (GO:1902803) | 2.94297255 |
| 117 | lysine metabolic process (GO:0006553) | 2.92147761 |
| 118 | lysine catabolic process (GO:0006554) | 2.92147761 |
| 119 | regulation of triglyceride metabolic process (GO:0090207) | 2.90259085 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 2.88350832 |
| 121 | histone H3-K4 trimethylation (GO:0080182) | 2.86701154 |
| 122 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.86514999 |
| 123 | negative regulation of lipase activity (GO:0060192) | 2.86213888 |
| 124 | homocysteine metabolic process (GO:0050667) | 2.84479391 |
| 125 | plasma lipoprotein particle clearance (GO:0034381) | 2.83777865 |
| 126 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.83320170 |
| 127 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.80714051 |
| 128 | protein import into peroxisome matrix (GO:0016558) | 2.79920785 |
| 129 | cellular glucuronidation (GO:0052695) | 2.77732909 |
| 130 | regulation of complement activation (GO:0030449) | 2.77647862 |
| 131 | locomotory exploration behavior (GO:0035641) | 2.77632870 |
| 132 | negative regulation of microtubule polymerization (GO:0031115) | 2.76883002 |
| 133 | regulation of cholesterol metabolic process (GO:0090181) | 2.76168294 |
| 134 | proline metabolic process (GO:0006560) | 2.75177465 |
| 135 | protein localization to endosome (GO:0036010) | 2.74692035 |
| 136 | layer formation in cerebral cortex (GO:0021819) | 2.74020446 |
| 137 | membrane tubulation (GO:0097320) | 2.71728907 |
| 138 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.71690878 |
| 139 | gluconeogenesis (GO:0006094) | 2.71041601 |
| 140 | regulation of cellular respiration (GO:0043457) | 2.70823171 |
| 141 | cholesterol homeostasis (GO:0042632) | 2.70492740 |
| 142 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.70437580 |
| 143 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.69760964 |
| 144 | adenosine receptor signaling pathway (GO:0001973) | 2.68982890 |
| 145 | lipoprotein metabolic process (GO:0042157) | 2.68769674 |
| 146 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.68510307 |
| 147 | histone arginine methylation (GO:0034969) | 2.68169695 |
| 148 | fructose metabolic process (GO:0006000) | 2.67519409 |
| 149 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.66272282 |
| 150 | positive regulation of neurotransmitter transport (GO:0051590) | 2.65707733 |
| 151 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.65303562 |
| 152 | dicarboxylic acid transport (GO:0006835) | 2.65051918 |
| 153 | positive regulation of glycogen metabolic process (GO:0070875) | 2.64628527 |
| 154 | positive regulation of dendritic spine development (GO:0060999) | 2.64247939 |
| 155 | drug transmembrane transport (GO:0006855) | 2.63910458 |
| 156 | sterol homeostasis (GO:0055092) | 2.61958193 |
| 157 | intestinal cholesterol absorption (GO:0030299) | 2.61786807 |
| 158 | hexose biosynthetic process (GO:0019319) | 2.61328864 |
| 159 | regulation of synapse maturation (GO:0090128) | 2.58890593 |
| 160 | cofactor catabolic process (GO:0051187) | 2.55730556 |
| 161 | ADP metabolic process (GO:0046031) | 2.53827919 |
| 162 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.52431487 |
| 163 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.52366242 |
| 164 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.51379342 |
| 165 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.51379342 |
| 166 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.50563973 |
| 167 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.50563973 |
| 168 | protein targeting to plasma membrane (GO:0072661) | 2.49851739 |
| 169 | regulation of mitochondrial translation (GO:0070129) | 2.48170487 |
| 170 | amino acid import (GO:0043090) | 2.48024134 |
| 171 | regulation of synaptic plasticity (GO:0048167) | 2.47696096 |
| 172 | cellular zinc ion homeostasis (GO:0006882) | 2.47497356 |
| 173 | peptidyl-histidine modification (GO:0018202) | 2.46610174 |
| 174 | positive regulation of actin filament depolymerization (GO:0030836) | 2.46107324 |
| 175 | protein localization to synapse (GO:0035418) | 2.45874084 |
| 176 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.41897700 |
| 177 | NADH metabolic process (GO:0006734) | 2.41056439 |
| 178 | AMP metabolic process (GO:0046033) | 2.39881267 |
| 179 | UTP biosynthetic process (GO:0006228) | 2.39493232 |
| 180 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.38862650 |
| 181 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.38862650 |
| 182 | regulation of protein sumoylation (GO:0033233) | 2.36565484 |
| 183 | monosaccharide biosynthetic process (GO:0046364) | 2.36163946 |
| 184 | pyrimidine nucleoside salvage (GO:0043097) | 2.35722846 |
| 185 | pyrimidine-containing compound salvage (GO:0008655) | 2.35722846 |
| 186 | peptidyl-arginine methylation (GO:0018216) | 2.35461485 |
| 187 | peptidyl-arginine N-methylation (GO:0035246) | 2.35461485 |
| 188 | barbed-end actin filament capping (GO:0051016) | 2.33572301 |
| 189 | GTP biosynthetic process (GO:0006183) | 2.33289535 |
| 190 | positive regulation of mitochondrion organization (GO:0010822) | 2.29687210 |
| 191 | exploration behavior (GO:0035640) | 2.27085200 |
| 192 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.26971252 |
| 193 | UV protection (GO:0009650) | 2.26696933 |
| 194 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.26330079 |
| 195 | positive regulation of TOR signaling (GO:0032008) | 2.25849253 |
| 196 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.25830145 |
| 197 | cellular copper ion homeostasis (GO:0006878) | 2.24712647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.17647220 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.41797179 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.68976001 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.23468993 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.07762164 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.36923487 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.17456370 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.12805288 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.06133074 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.69937769 |
| 11 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.60205369 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.51938014 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.39990968 |
| 14 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.35003246 |
| 15 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.24613919 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17693870 |
| 17 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.13129416 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.12031844 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.04683212 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.03317283 |
| 21 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.00977869 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.95799232 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.91063608 |
| 24 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.88460181 |
| 25 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.87047504 |
| 26 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.82497270 |
| 27 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.77799646 |
| 28 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.77797708 |
| 29 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.76904486 |
| 30 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.73271770 |
| 31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.72094794 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71862260 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.71644995 |
| 34 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.70860210 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.70775298 |
| 36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70401891 |
| 37 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.69622207 |
| 38 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.68667012 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.65018414 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63266632 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61298009 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.59651078 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59159863 |
| 44 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.56811905 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56174555 |
| 46 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.55508355 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55391151 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54486551 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51886975 |
| 50 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51344197 |
| 51 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51175753 |
| 52 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48991290 |
| 53 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.45634029 |
| 54 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43864192 |
| 55 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.42121457 |
| 56 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40409546 |
| 57 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40369094 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39482663 |
| 59 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38753199 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38595498 |
| 61 | MYC_22102868_ChIP-Seq_BL_Human | 1.37415994 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36182401 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35842969 |
| 64 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.35736831 |
| 65 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.34307804 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33802200 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32367541 |
| 68 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30351825 |
| 69 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.29306355 |
| 70 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28458552 |
| 71 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.28361696 |
| 72 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28241804 |
| 73 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.27441451 |
| 74 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.26007005 |
| 75 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.25904230 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25403091 |
| 77 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.24243612 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24116090 |
| 79 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.23426641 |
| 80 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.23379571 |
| 81 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.23217503 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.23084912 |
| 83 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22796766 |
| 84 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22404883 |
| 85 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.21958203 |
| 86 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.20935316 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20750446 |
| 88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20354638 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19067936 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18236386 |
| 91 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18130080 |
| 92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.18125626 |
| 93 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17514320 |
| 94 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17218271 |
| 95 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16176275 |
| 96 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15743114 |
| 97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15513814 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15103077 |
| 99 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.14981732 |
| 100 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.14741734 |
| 101 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.13801250 |
| 102 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.12257274 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11721343 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10946363 |
| 105 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.09965798 |
| 106 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09378180 |
| 107 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.09192505 |
| 108 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08419719 |
| 109 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08378030 |
| 110 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08366006 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07219126 |
| 112 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.06954968 |
| 113 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06884294 |
| 114 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.06670498 |
| 115 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06322870 |
| 116 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.05209329 |
| 117 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04682512 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04653944 |
| 119 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04446803 |
| 120 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02876486 |
| 121 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02277484 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 1.02255709 |
| 123 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01525530 |
| 124 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01405379 |
| 125 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01183663 |
| 126 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01178760 |
| 127 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.00892332 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00838058 |
| 129 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00768529 |
| 130 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98373133 |
| 131 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98228003 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97924643 |
| 133 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96210912 |
| 134 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.94958392 |
| 135 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94772310 |
| 136 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.94642832 |
| 137 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93942479 |
| 138 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93942479 |
| 139 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93685920 |
| 140 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93598670 |
| 141 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93112946 |
| 142 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91285302 |
| 143 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90492450 |
| 144 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.90390912 |
| 145 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88839135 |
| 146 | AR_19668381_ChIP-Seq_PC3_Human | 0.88402286 |
| 147 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.88275973 |
| 148 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87319130 |
| 149 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.83863576 |
| 150 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83541873 |
| 151 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83502956 |
| 152 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.83251486 |
| 153 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81568232 |
| 154 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81501347 |
| 155 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80900203 |
| 156 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.80541204 |
| 157 | P68_20966046_ChIP-Seq_HELA_Human | 0.80129258 |
| 158 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80078825 |
| 159 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79980357 |
| 160 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.79828000 |
| 161 | MAF_26560356_Chip-Seq_TH1_Human | 0.79721351 |
| 162 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.79564116 |
| 163 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78422109 |
| 164 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77478418 |
| 165 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.76836514 |
| 166 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.76724982 |
| 167 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.75502917 |
| 168 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.74247978 |
| 169 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.74242879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.28552118 |
| 2 | MP0005360_urolithiasis | 5.36886566 |
| 3 | MP0005365_abnormal_bile_salt | 5.01815541 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.74592287 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.87946842 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.39511386 |
| 7 | MP0003252_abnormal_bile_duct | 3.31764429 |
| 8 | MP0003868_abnormal_feces_composition | 3.10127777 |
| 9 | MP0003880_abnormal_central_pattern | 3.05557051 |
| 10 | MP0004270_analgesia | 3.04570666 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.97459877 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.77455291 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.71387538 |
| 14 | MP0005670_abnormal_white_adipose | 2.71099085 |
| 15 | MP0009840_abnormal_foam_cell | 2.66529002 |
| 16 | MP0003123_paternal_imprinting | 2.63156612 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.58618747 |
| 18 | MP0002064_seizures | 2.46518431 |
| 19 | MP0005083_abnormal_biliary_tract | 2.22603024 |
| 20 | MP0000749_muscle_degeneration | 2.21701654 |
| 21 | MP0010030_abnormal_orbit_morphology | 2.16048720 |
| 22 | MP0003879_abnormal_hair_cell | 2.12213521 |
| 23 | MP0008961_abnormal_basal_metabolism | 2.09052851 |
| 24 | MP0003011_delayed_dark_adaptation | 2.03132997 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.00015224 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.98172984 |
| 27 | MP0000609_abnormal_liver_physiology | 1.97847512 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.97634267 |
| 29 | MP0009745_abnormal_behavioral_response | 1.91884165 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.84763755 |
| 31 | MP0002063_abnormal_learning/memory/cond | 1.84178889 |
| 32 | MP0008260_abnormal_autophagy | 1.82285610 |
| 33 | MP0005623_abnormal_meninges_morphology | 1.77596291 |
| 34 | MP0001502_abnormal_circadian_rhythm | 1.77403192 |
| 35 | MP0005220_abnormal_exocrine_pancreas | 1.72691945 |
| 36 | MP0005332_abnormal_amino_acid | 1.72169430 |
| 37 | MP0004233_abnormal_muscle_weight | 1.71232080 |
| 38 | MP0000537_abnormal_urethra_morphology | 1.69297662 |
| 39 | MP0002249_abnormal_larynx_morphology | 1.68292347 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.66710374 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.65269142 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.64025719 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.61320072 |
| 44 | MP0009046_muscle_twitch | 1.58510256 |
| 45 | MP0005253_abnormal_eye_physiology | 1.55819468 |
| 46 | MP0004885_abnormal_endolymph | 1.55377078 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.54533552 |
| 48 | MP0002734_abnormal_mechanical_nocicepti | 1.51287290 |
| 49 | MP0005334_abnormal_fat_pad | 1.50919968 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.50654434 |
| 51 | MP0002736_abnormal_nociception_after | 1.50254709 |
| 52 | MP0002272_abnormal_nervous_system | 1.50130352 |
| 53 | MP0003075_altered_response_to | 1.48578919 |
| 54 | MP0004147_increased_porphyrin_level | 1.48235512 |
| 55 | MP0001905_abnormal_dopamine_level | 1.47151730 |
| 56 | MP0001346_abnormal_lacrimal_gland | 1.43985309 |
| 57 | MP0002971_abnormal_brown_adipose | 1.30638674 |
| 58 | MP0005257_abnormal_intraocular_pressure | 1.29624228 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.28825815 |
| 60 | MP0001873_stomach_inflammation | 1.28317089 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.27492429 |
| 62 | MP0004130_abnormal_muscle_cell | 1.26328820 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.22462251 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 1.21540208 |
| 65 | MP0005195_abnormal_posterior_eye | 1.14684373 |
| 66 | MP0002735_abnormal_chemical_nociception | 1.14142566 |
| 67 | MP0001970_abnormal_pain_threshold | 1.13219345 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.12923409 |
| 69 | MP0004510_myositis | 1.11748069 |
| 70 | MP0002234_abnormal_pharynx_morphology | 1.08735882 |
| 71 | MP0009384_cardiac_valve_regurgitation | 1.08602186 |
| 72 | MP0000681_abnormal_thyroid_gland | 1.08288620 |
| 73 | MP0005501_abnormal_skin_physiology | 1.08027567 |
| 74 | MP0004811_abnormal_neuron_physiology | 1.07924588 |
| 75 | MP0004858_abnormal_nervous_system | 1.07305101 |
| 76 | MP0000685_abnormal_immune_system | 1.06900078 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 1.06075905 |
| 78 | MP0000920_abnormal_myelination | 1.06049110 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 1.05739306 |
| 80 | MP0003300_gastrointestinal_ulcer | 1.05480515 |
| 81 | MP0004019_abnormal_vitamin_homeostasis | 1.03725821 |
| 82 | MP0002733_abnormal_thermal_nociception | 1.03572365 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03498873 |
| 84 | MP0001188_hyperpigmentation | 1.01227719 |
| 85 | MP0000759_abnormal_skeletal_muscle | 1.00360858 |
| 86 | MP0002970_abnormal_white_adipose | 1.00175682 |
| 87 | MP0001849_ear_inflammation | 1.00113978 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 0.97193191 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 0.96578521 |
| 90 | MP0003866_abnormal_defecation | 0.96361332 |
| 91 | MP0002090_abnormal_vision | 0.95404773 |
| 92 | MP0001324_abnormal_eye_pigmentation | 0.94868961 |
| 93 | MP0003634_abnormal_glial_cell | 0.93374933 |
| 94 | MP0003329_amyloid_beta_deposits | 0.92286593 |
| 95 | MP0005451_abnormal_body_composition | 0.91433188 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.91333373 |
| 97 | MP0000733_abnormal_muscle_development | 0.90385987 |
| 98 | MP0008775_abnormal_heart_ventricle | 0.89500975 |
| 99 | MP0005165_increased_susceptibility_to | 0.88818126 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.88683873 |
| 101 | MP0000598_abnormal_liver_morphology | 0.87911036 |
| 102 | MP0004036_abnormal_muscle_relaxation | 0.87722046 |
| 103 | MP0005647_abnormal_sex_gland | 0.87708442 |
| 104 | MP0002229_neurodegeneration | 0.87588604 |
| 105 | MP0001486_abnormal_startle_reflex | 0.87548659 |
| 106 | MP0001764_abnormal_homeostasis | 0.87475101 |
| 107 | MP0000013_abnormal_adipose_tissue | 0.87199014 |
| 108 | MP0003315_abnormal_perineum_morphology | 0.86642372 |
| 109 | MP0005448_abnormal_energy_balance | 0.85774223 |
| 110 | MP0001661_extended_life_span | 0.85585523 |
| 111 | MP0002269_muscular_atrophy | 0.85380258 |
| 112 | MP0003953_abnormal_hormone_level | 0.85088302 |
| 113 | MP0009672_abnormal_birth_weight | 0.85058329 |
| 114 | MP0003279_aneurysm | 0.84554087 |
| 115 | MP0001984_abnormal_olfaction | 0.83890428 |
| 116 | MP0000604_amyloidosis | 0.82487890 |
| 117 | MP0005166_decreased_susceptibility_to | 0.81083775 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.79600257 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.79567246 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.79472553 |
| 121 | MP0009642_abnormal_blood_homeostasis | 0.79364224 |
| 122 | MP0002882_abnormal_neuron_morphology | 0.77581733 |
| 123 | MP0008874_decreased_physiological_sensi | 0.77018467 |
| 124 | MP0003693_abnormal_embryo_hatching | 0.76672008 |
| 125 | MP0004859_abnormal_synaptic_plasticity | 0.76045066 |
| 126 | MP0004087_abnormal_muscle_fiber | 0.75964582 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.75897321 |
| 128 | MP0005330_cardiomyopathy | 0.74835798 |
| 129 | MP0005391_vision/eye_phenotype | 0.74780747 |
| 130 | MP0003631_nervous_system_phenotype | 0.74113734 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.73826989 |
| 132 | MP0004084_abnormal_cardiac_muscle | 0.72537983 |
| 133 | MP0000762_abnormal_tongue_morphology | 0.72053511 |
| 134 | MP0005248_abnormal_Harderian_gland | 0.70845849 |
| 135 | MP0000747_muscle_weakness | 0.70362351 |
| 136 | MP0003633_abnormal_nervous_system | 0.69851682 |
| 137 | MP0005423_abnormal_somatic_nervous | 0.69491516 |
| 138 | MP0000534_abnormal_ureter_morphology | 0.68775024 |
| 139 | MP0001348_abnormal_lacrimal_gland | 0.68228903 |
| 140 | MP0002067_abnormal_sensory_capabilities | 0.68188467 |
| 141 | MP0010771_integument_phenotype | 0.67851204 |
| 142 | MP0009643_abnormal_urine_homeostasis | 0.66907072 |
| 143 | MP0000751_myopathy | 0.66791046 |
| 144 | MP0003453_abnormal_keratinocyte_physiol | 0.66502657 |
| 145 | MP0002909_abnormal_adrenal_gland | 0.65979102 |
| 146 | MP0002060_abnormal_skin_morphology | 0.65408215 |
| 147 | MP0008932_abnormal_embryonic_tissue | 0.64552795 |
| 148 | MP0000955_abnormal_spinal_cord | 0.64504540 |
| 149 | MP0005535_abnormal_body_temperature | 0.63637492 |
| 150 | MP0002557_abnormal_social/conspecific_i | 0.63583335 |
| 151 | MP0009115_abnormal_fat_cell | 0.63155760 |
| 152 | MP0005464_abnormal_platelet_physiology | 0.62970664 |
| 153 | MP0009697_abnormal_copulation | 0.62500320 |
| 154 | MP0002796_impaired_skin_barrier | 0.62412522 |
| 155 | MP0002127_abnormal_cardiovascular_syste | 0.62006150 |
| 156 | MP0005645_abnormal_hypothalamus_physiol | 0.61372140 |
| 157 | MP0005171_absent_coat_pigmentation | 0.61250580 |
| 158 | MP0010630_abnormal_cardiac_muscle | 0.60347209 |
| 159 | MP0002837_dystrophic_cardiac_calcinosis | 0.60036847 |
| 160 | MP0008569_lethality_at_weaning | 0.59765527 |
| 161 | MP0002069_abnormal_eating/drinking_beha | 0.59327112 |
| 162 | MP0003172_abnormal_lysosome_physiology | 0.59203836 |
| 163 | MP0002295_abnormal_pulmonary_circulatio | 0.58838237 |
| 164 | MP0003183_abnormal_peptide_metabolism | 0.58667092 |
| 165 | MP0001501_abnormal_sleep_pattern | 0.55557930 |
| 166 | MP0009763_increased_sensitivity_to | 0.55530666 |
| 167 | MP0005452_abnormal_adipose_tissue | 0.55490477 |
| 168 | MP0002928_abnormal_bile_duct | 0.55053996 |
| 169 | MP0005646_abnormal_pituitary_gland | 0.54771242 |
| 170 | MP0001853_heart_inflammation | 0.52934964 |
| 171 | MP0003115_abnormal_respiratory_system | 0.52510997 |
| 172 | MP0008872_abnormal_physiological_respon | 0.51461691 |
| 173 | MP0000639_abnormal_adrenal_gland | 0.50524003 |
| 174 | MP0008877_abnormal_DNA_methylation | 0.50405795 |
| 175 | MP0002822_catalepsy | 0.49747470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 5.20621384 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.15672160 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.80509049 |
| 4 | Hyperlipoproteinemia (HP:0010980) | 4.71960902 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 4.57585320 |
| 6 | Myokymia (HP:0002411) | 4.34241029 |
| 7 | Xanthomatosis (HP:0000991) | 4.32293995 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 4.26684084 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.18122256 |
| 10 | Central scotoma (HP:0000603) | 3.88435506 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.67497312 |
| 12 | Abnormality of methionine metabolism (HP:0010901) | 3.53076243 |
| 13 | Macroorchidism (HP:0000053) | 3.40209237 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.39635837 |
| 15 | Ketosis (HP:0001946) | 3.39114945 |
| 16 | Pigmentary retinal degeneration (HP:0001146) | 3.30683088 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.26855402 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.23469479 |
| 19 | Insomnia (HP:0100785) | 3.14361765 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.11997095 |
| 21 | Testicular atrophy (HP:0000029) | 3.08775980 |
| 22 | Delusions (HP:0000746) | 3.05493615 |
| 23 | Visual hallucinations (HP:0002367) | 3.04165918 |
| 24 | Vertebral compression fractures (HP:0002953) | 3.03404427 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 2.98735393 |
| 26 | Chorioretinal atrophy (HP:0000533) | 2.96055796 |
| 27 | Cerebral hypomyelination (HP:0006808) | 2.95767264 |
| 28 | Distal upper limb amyotrophy (HP:0007149) | 2.94157549 |
| 29 | Upper limb amyotrophy (HP:0009129) | 2.94157549 |
| 30 | Annular pancreas (HP:0001734) | 2.92805325 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.91231160 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 2.91215075 |
| 33 | Myoglobinuria (HP:0002913) | 2.90847252 |
| 34 | Hypercholesterolemia (HP:0003124) | 2.88599696 |
| 35 | Joint hemorrhage (HP:0005261) | 2.88522257 |
| 36 | Large for gestational age (HP:0001520) | 2.86069295 |
| 37 | Ketoacidosis (HP:0001993) | 2.85286467 |
| 38 | Gingival bleeding (HP:0000225) | 2.83259117 |
| 39 | Hypolipoproteinemia (HP:0010981) | 2.83198789 |
| 40 | Achilles tendon contracture (HP:0001771) | 2.82283865 |
| 41 | Hyperammonemia (HP:0001987) | 2.80471645 |
| 42 | Scotoma (HP:0000575) | 2.75377859 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.73992367 |
| 44 | Hypoglycemic seizures (HP:0002173) | 2.72563426 |
| 45 | Difficulty climbing stairs (HP:0003551) | 2.66747897 |
| 46 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.66371987 |
| 47 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.66371987 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.65199970 |
| 49 | Back pain (HP:0003418) | 2.62393849 |
| 50 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.60934844 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.60327569 |
| 52 | Amblyopia (HP:0000646) | 2.59548723 |
| 53 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.58321701 |
| 54 | Epidermoid cyst (HP:0200040) | 2.57473948 |
| 55 | Decreased central vision (HP:0007663) | 2.55845190 |
| 56 | Premature rupture of membranes (HP:0001788) | 2.54657083 |
| 57 | Truncal ataxia (HP:0002078) | 2.52052620 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.51663267 |
| 59 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.49700195 |
| 60 | Hand muscle atrophy (HP:0009130) | 2.47543314 |
| 61 | Ankle clonus (HP:0011448) | 2.45763912 |
| 62 | Pseudobulbar signs (HP:0002200) | 2.44790813 |
| 63 | Ulnar bowing (HP:0003031) | 2.44657288 |
| 64 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.44523094 |
| 65 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.44523094 |
| 66 | Abnormality of the Achilles tendon (HP:0005109) | 2.44345739 |
| 67 | Hypokinesia (HP:0002375) | 2.42895585 |
| 68 | Pendular nystagmus (HP:0012043) | 2.42483627 |
| 69 | Focal motor seizures (HP:0011153) | 2.41338704 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 2.40342128 |
| 71 | Neonatal onset (HP:0003623) | 2.40333194 |
| 72 | Hyperbilirubinemia (HP:0002904) | 2.39712636 |
| 73 | Myopathic facies (HP:0002058) | 2.38005505 |
| 74 | Stridor (HP:0010307) | 2.36386948 |
| 75 | Complement deficiency (HP:0004431) | 2.35469320 |
| 76 | Symptomatic seizures (HP:0011145) | 2.35047244 |
| 77 | Depression (HP:0000716) | 2.33256592 |
| 78 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.29785498 |
| 79 | Enlarged kidneys (HP:0000105) | 2.28607998 |
| 80 | Axonal loss (HP:0003447) | 2.28512724 |
| 81 | Epileptic encephalopathy (HP:0200134) | 2.27402423 |
| 82 | Severe visual impairment (HP:0001141) | 2.22721183 |
| 83 | Increased muscle lipid content (HP:0009058) | 2.22010811 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.21596973 |
| 85 | Hypochromic microcytic anemia (HP:0004840) | 2.20270400 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20073775 |
| 87 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.19062221 |
| 88 | Abnormality of glycine metabolism (HP:0010895) | 2.18611391 |
| 89 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.18611391 |
| 90 | Unilateral renal agenesis (HP:0000122) | 2.18457176 |
| 91 | Abnormality of the fingertips (HP:0001211) | 2.16569197 |
| 92 | Spinal rigidity (HP:0003306) | 2.15782285 |
| 93 | Truncus arteriosus (HP:0001660) | 2.15463256 |
| 94 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14886328 |
| 95 | Hyperglycinuria (HP:0003108) | 2.14341228 |
| 96 | Enlarged penis (HP:0000040) | 2.12042850 |
| 97 | Distal lower limb amyotrophy (HP:0008944) | 2.07148779 |
| 98 | Acanthocytosis (HP:0001927) | 2.06010367 |
| 99 | Late onset (HP:0003584) | 2.05663233 |
| 100 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05647044 |
| 101 | Macular degeneration (HP:0000608) | 2.04035869 |
| 102 | Hyperglycinemia (HP:0002154) | 2.02443052 |
| 103 | Neurofibrillary tangles (HP:0002185) | 2.00931976 |
| 104 | Hydroureter (HP:0000072) | 2.00855807 |
| 105 | Akinesia (HP:0002304) | 2.00722400 |
| 106 | Rough bone trabeculation (HP:0100670) | 1.99835801 |
| 107 | Microretrognathia (HP:0000308) | 1.99798588 |
| 108 | Confusion (HP:0001289) | 1.99646424 |
| 109 | Poikilocytosis (HP:0004447) | 1.99032067 |
| 110 | Retinal dysplasia (HP:0007973) | 1.98938331 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 1.98846117 |
| 112 | Biconcave vertebral bodies (HP:0004586) | 1.98173846 |
| 113 | Renal Fanconi syndrome (HP:0001994) | 1.98077500 |
| 114 | Status epilepticus (HP:0002133) | 1.97950804 |
| 115 | Poor eye contact (HP:0000817) | 1.97707993 |
| 116 | Diaphragmatic weakness (HP:0009113) | 1.97037031 |
| 117 | Neuronal loss in central nervous system (HP:0002529) | 1.96878233 |
| 118 | Emotional lability (HP:0000712) | 1.96702774 |
| 119 | Hypochromic anemia (HP:0001931) | 1.95829737 |
| 120 | Abolished electroretinogram (ERG) (HP:0000550) | 1.95461029 |
| 121 | Bulbar palsy (HP:0001283) | 1.94955118 |
| 122 | Fat malabsorption (HP:0002630) | 1.94348755 |
| 123 | Abnormal platelet volume (HP:0011876) | 1.93863572 |
| 124 | Overlapping toe (HP:0001845) | 1.93802182 |
| 125 | Progressive muscle weakness (HP:0003323) | 1.93736210 |
| 126 | Thin bony cortex (HP:0002753) | 1.92724072 |
| 127 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.91826714 |
| 128 | Hemiplegia (HP:0002301) | 1.90038017 |
| 129 | Generalized amyotrophy (HP:0003700) | 1.89265821 |
| 130 | Cholecystitis (HP:0001082) | 1.89216998 |
| 131 | Abnormal gallbladder physiology (HP:0012438) | 1.89216998 |
| 132 | Severe muscular hypotonia (HP:0006829) | 1.88932229 |
| 133 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88755504 |
| 134 | Dicarboxylic aciduria (HP:0003215) | 1.88755504 |
| 135 | Heterotopia (HP:0002282) | 1.88630780 |
| 136 | Abnormality of iron homeostasis (HP:0011031) | 1.87977969 |
| 137 | Delayed CNS myelination (HP:0002188) | 1.87861315 |
| 138 | Athetosis (HP:0002305) | 1.87639224 |
| 139 | Congenital malformation of the right heart (HP:0011723) | 1.87454222 |
| 140 | Double outlet right ventricle (HP:0001719) | 1.87454222 |
| 141 | Panhypogammaglobulinemia (HP:0003139) | 1.87345623 |
| 142 | Gastrointestinal inflammation (HP:0004386) | 1.87160069 |
| 143 | Reticulocytosis (HP:0001923) | 1.86131289 |
| 144 | Focal dystonia (HP:0004373) | 1.86031711 |
| 145 | Mitral stenosis (HP:0001718) | 1.85845707 |
| 146 | Dyschromatopsia (HP:0007641) | 1.85196623 |
| 147 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.84938594 |
| 148 | Focal seizures (HP:0007359) | 1.84821929 |
| 149 | Hemorrhage of the eye (HP:0011885) | 1.84773022 |
| 150 | Hepatocellular necrosis (HP:0001404) | 1.84721806 |
| 151 | Obsessive-compulsive behavior (HP:0000722) | 1.84156210 |
| 152 | Hyperacusis (HP:0010780) | 1.83480346 |
| 153 | Broad distal phalanx of finger (HP:0009836) | 1.83194923 |
| 154 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.83128855 |
| 155 | Abnormal atrioventricular conduction (HP:0005150) | 1.81147885 |
| 156 | Craniofacial dystonia (HP:0012179) | 1.80916760 |
| 157 | Prolonged neonatal jaundice (HP:0006579) | 1.80060878 |
| 158 | Foot dorsiflexor weakness (HP:0009027) | 1.79798509 |
| 159 | Diminished movement (HP:0002374) | 1.78770012 |
| 160 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.78563001 |
| 161 | Lower limb amyotrophy (HP:0007210) | 1.77496522 |
| 162 | Obstructive sleep apnea (HP:0002870) | 1.77189605 |
| 163 | Abnormal trabecular bone morphology (HP:0100671) | 1.77165954 |
| 164 | Supernumerary nipples (HP:0002558) | 1.77052564 |
| 165 | Gout (HP:0001997) | 1.76862662 |
| 166 | Abnormality of glycolysis (HP:0004366) | 1.76032176 |
| 167 | Torticollis (HP:0000473) | 1.75826461 |
| 168 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.75619533 |
| 169 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75619533 |
| 170 | Abnormality of glycolipid metabolism (HP:0010969) | 1.75619533 |
| 171 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.75600886 |
| 172 | Cholelithiasis (HP:0001081) | 1.74973805 |
| 173 | Elbow flexion contracture (HP:0002987) | 1.74496275 |
| 174 | Menorrhagia (HP:0000132) | 1.74226146 |
| 175 | Abnormal gallbladder morphology (HP:0012437) | 1.73641589 |
| 176 | Spinal cord compression (HP:0002176) | 1.72983978 |
| 177 | Congenital glaucoma (HP:0001087) | 1.71678375 |
| 178 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70821973 |
| 179 | Unsteady gait (HP:0002317) | 1.69665518 |
| 180 | Transposition of the great arteries (HP:0001669) | 1.69657536 |
| 181 | Abnormal connection of the cardiac segments (HP:0011545) | 1.69657536 |
| 182 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.69657536 |
| 183 | Limb-girdle muscle atrophy (HP:0003797) | 1.68876207 |
| 184 | Hyperthyroidism (HP:0000836) | 1.68463234 |
| 185 | Myocardial infarction (HP:0001658) | 1.68389674 |
| 186 | Acute hepatic failure (HP:0006554) | 1.68210562 |
| 187 | Rapidly progressive (HP:0003678) | 1.68152964 |
| 188 | Exercise intolerance (HP:0003546) | 1.67477152 |
| 189 | Mitochondrial inheritance (HP:0001427) | 1.66192545 |
| 190 | Increased hepatocellular lipid droplets (HP:0006565) | 1.65139069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.05251399 |
| 2 | SIK1 | 4.01601056 |
| 3 | VRK2 | 3.33947703 |
| 4 | ARAF | 3.30839728 |
| 5 | TRIB3 | 3.26844770 |
| 6 | SIK2 | 3.22213125 |
| 7 | TESK1 | 2.99913766 |
| 8 | PRKD3 | 2.97187592 |
| 9 | SMG1 | 2.93030498 |
| 10 | PKN2 | 2.89020897 |
| 11 | ERN1 | 2.65554724 |
| 12 | FGFR4 | 2.64591188 |
| 13 | IRAK3 | 2.63180996 |
| 14 | MAP3K10 | 2.50740788 |
| 15 | EEF2K | 2.45657891 |
| 16 | EPHA2 | 2.35880096 |
| 17 | SIK3 | 2.33745887 |
| 18 | LIMK1 | 2.31117892 |
| 19 | CAMK1D | 2.30471886 |
| 20 | INSRR | 2.29588555 |
| 21 | MAP3K7 | 2.19933490 |
| 22 | TESK2 | 2.13169125 |
| 23 | CAMK1G | 2.07903619 |
| 24 | TNIK | 1.99149874 |
| 25 | MAP3K11 | 1.94746242 |
| 26 | MAP4K1 | 1.92995576 |
| 27 | GRK5 | 1.88028094 |
| 28 | FLT3 | 1.74433578 |
| 29 | BUB1 | 1.74389939 |
| 30 | DAPK1 | 1.74284260 |
| 31 | PTK6 | 1.70396980 |
| 32 | BCKDK | 1.69772294 |
| 33 | RIPK1 | 1.65718996 |
| 34 | NTRK2 | 1.64858234 |
| 35 | PIM2 | 1.59215517 |
| 36 | FGFR3 | 1.43541186 |
| 37 | MARK2 | 1.43416243 |
| 38 | STK38 | 1.38931349 |
| 39 | DAPK2 | 1.29474482 |
| 40 | BRD4 | 1.28501118 |
| 41 | BRAF | 1.27846133 |
| 42 | TYK2 | 1.27498885 |
| 43 | ABL2 | 1.26263055 |
| 44 | PRPF4B | 1.25652800 |
| 45 | CDK15 | 1.19552664 |
| 46 | BRSK1 | 1.18536164 |
| 47 | MST1R | 1.15837530 |
| 48 | FGFR2 | 1.15473309 |
| 49 | CDK18 | 1.15431553 |
| 50 | CDK11A | 1.15152384 |
| 51 | TNK2 | 1.13505984 |
| 52 | CDK14 | 1.09379693 |
| 53 | BTK | 1.08468410 |
| 54 | MAP3K9 | 1.07577021 |
| 55 | PRKAA2 | 1.07414289 |
| 56 | IRAK2 | 1.07277795 |
| 57 | ICK | 1.06588417 |
| 58 | EPHB1 | 1.02407282 |
| 59 | DAPK3 | 1.01640550 |
| 60 | MAP2K3 | 1.01591296 |
| 61 | MAPK11 | 1.00889044 |
| 62 | ITK | 1.00351675 |
| 63 | LATS2 | 0.99779251 |
| 64 | PRKG2 | 0.98547987 |
| 65 | CAMK2G | 0.98443621 |
| 66 | CSF1R | 0.98390229 |
| 67 | STK16 | 0.98308007 |
| 68 | TAOK3 | 0.96711438 |
| 69 | NTRK1 | 0.95425473 |
| 70 | CDK12 | 0.94540868 |
| 71 | JAK1 | 0.93874251 |
| 72 | CAMK1 | 0.92985688 |
| 73 | MAP2K2 | 0.90788277 |
| 74 | PDGFRA | 0.89214180 |
| 75 | AURKA | 0.88136688 |
| 76 | CSNK1G3 | 0.87771560 |
| 77 | PDK2 | 0.87556959 |
| 78 | PAK4 | 0.87113449 |
| 79 | EPHA4 | 0.86491944 |
| 80 | SGK3 | 0.85170461 |
| 81 | PRKD2 | 0.85044095 |
| 82 | MAP2K6 | 0.84163232 |
| 83 | MAPK15 | 0.84093763 |
| 84 | CSNK1A1L | 0.84050528 |
| 85 | LMTK2 | 0.82436012 |
| 86 | MAP3K12 | 0.82390138 |
| 87 | MINK1 | 0.81813688 |
| 88 | GRK6 | 0.80568388 |
| 89 | CAMK2B | 0.79511415 |
| 90 | ILK | 0.77855358 |
| 91 | PTK2 | 0.77662377 |
| 92 | CAMK4 | 0.77560761 |
| 93 | HIPK2 | 0.77239969 |
| 94 | HCK | 0.76515978 |
| 95 | PRKAA1 | 0.76418927 |
| 96 | LATS1 | 0.75236487 |
| 97 | CAMKK1 | 0.74891865 |
| 98 | DYRK1B | 0.74584824 |
| 99 | PAK6 | 0.72876090 |
| 100 | KIT | 0.72593311 |
| 101 | UHMK1 | 0.71988815 |
| 102 | MAP2K7 | 0.70483931 |
| 103 | STK24 | 0.69852591 |
| 104 | PHKG1 | 0.69478680 |
| 105 | PHKG2 | 0.69478680 |
| 106 | FGFR1 | 0.68771945 |
| 107 | GRK1 | 0.68575644 |
| 108 | JAK3 | 0.68300729 |
| 109 | DMPK | 0.68253221 |
| 110 | TAF1 | 0.67921606 |
| 111 | MTOR | 0.66087647 |
| 112 | EPHB2 | 0.65412800 |
| 113 | PAK1 | 0.65140199 |
| 114 | SYK | 0.64206055 |
| 115 | MAPK12 | 0.64020225 |
| 116 | MAP3K1 | 0.63894113 |
| 117 | CDK5 | 0.63460648 |
| 118 | TTN | 0.62659231 |
| 119 | RET | 0.62209254 |
| 120 | CDC42BPA | 0.61211222 |
| 121 | MAPKAPK3 | 0.60668076 |
| 122 | MOS | 0.60012537 |
| 123 | JAK2 | 0.59919989 |
| 124 | PINK1 | 0.58763039 |
| 125 | DYRK1A | 0.58287005 |
| 126 | PDGFRB | 0.58272135 |
| 127 | TYRO3 | 0.57729941 |
| 128 | PRKCH | 0.57344363 |
| 129 | MAP3K6 | 0.57166479 |
| 130 | CDK8 | 0.56010754 |
| 131 | ERBB2 | 0.55466415 |
| 132 | SCYL2 | 0.54835724 |
| 133 | PIK3CA | 0.54542075 |
| 134 | PTK2B | 0.53249725 |
| 135 | PDK1 | 0.50636351 |
| 136 | TBK1 | 0.49744962 |
| 137 | PRKCI | 0.49260429 |
| 138 | PDPK1 | 0.47787109 |
| 139 | CCNB1 | 0.47490963 |
| 140 | MAP3K3 | 0.46919332 |
| 141 | SGK2 | 0.46136396 |
| 142 | PRKCZ | 0.45719603 |
| 143 | EIF2AK1 | 0.45551377 |
| 144 | CSNK1G2 | 0.44942894 |
| 145 | NTRK3 | 0.44249082 |
| 146 | BMX | 0.44186926 |
| 147 | MAPK4 | 0.43108758 |
| 148 | MUSK | 0.43045378 |
| 149 | MYLK | 0.42068507 |
| 150 | RPS6KA4 | 0.41645706 |
| 151 | CSK | 0.41421815 |
| 152 | PRKACG | 0.40906200 |
| 153 | MAPKAPK5 | 0.40561650 |
| 154 | TAOK2 | 0.40477141 |
| 155 | IKBKE | 0.39986290 |
| 156 | SGK223 | 0.39824453 |
| 157 | SGK494 | 0.39824453 |
| 158 | CHUK | 0.39331365 |
| 159 | CDK7 | 0.39036866 |
| 160 | KSR2 | 0.38478213 |
| 161 | PRKCB | 0.37400495 |
| 162 | NME1 | 0.36853132 |
| 163 | SRC | 0.36685895 |
| 164 | AKT2 | 0.36668017 |
| 165 | RPS6KA2 | 0.35867861 |
| 166 | LCK | 0.35635075 |
| 167 | MAP3K8 | 0.35319127 |
| 168 | RPS6KA3 | 0.35298227 |
| 169 | CAMK2D | 0.35219501 |
| 170 | PAK3 | 0.34647248 |
| 171 | MARK1 | 0.33924884 |
| 172 | MET | 0.33772489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.38552926 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.30667039 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.29642661 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.16738710 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77497415 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.72721135 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.64893477 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.53405012 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50452760 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.44800225 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.20958294 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.19131122 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.17932424 |
| 14 | Lysine degradation_Homo sapiens_hsa00310 | 2.13170881 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.10093782 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.06837079 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.05780532 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95532256 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92208597 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.89405349 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.86590794 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.82421298 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82059395 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.73279166 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.70770000 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.67319464 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.66974630 |
| 28 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.61919634 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.60899592 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60840277 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.60745303 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.57619919 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.48839822 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39778908 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.37506029 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37471493 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.37050923 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36076749 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35543171 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.32135206 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26327464 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25768030 |
| 43 | Proteasome_Homo sapiens_hsa03050 | 1.24834684 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 1.24411330 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.22229852 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.21227954 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 1.19570320 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.18836982 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18222578 |
| 50 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.18049476 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17320133 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16227175 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.16199776 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12976304 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.10918048 |
| 56 | Long-term potentiation_Homo sapiens_hsa04720 | 1.09138352 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08473772 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08050315 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.07077741 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06417122 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05971343 |
| 62 | Base excision repair_Homo sapiens_hsa03410 | 1.05575737 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03765098 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03555161 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01024312 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99652574 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.99012249 |
| 68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.98442173 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98369937 |
| 70 | Ribosome_Homo sapiens_hsa03010 | 0.96763549 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96282731 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95478350 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 0.93832542 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89318086 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.87057438 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86402235 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85676339 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.85483773 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81327580 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81107327 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.81097357 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.79884123 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79827746 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79597544 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78313931 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78286221 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77440146 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75663271 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75167832 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75137394 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74009478 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73552911 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71683696 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69870836 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67924935 |
| 96 | Nicotine addiction_Homo sapiens_hsa05033 | 0.67394016 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.66053021 |
| 98 | Gap junction_Homo sapiens_hsa04540 | 0.64123053 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.64023654 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63925364 |
| 101 | RNA polymerase_Homo sapiens_hsa03020 | 0.63913761 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63215734 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62856675 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62790046 |
| 105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62309110 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61458762 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60294555 |
| 108 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59866023 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59752507 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59633590 |
| 111 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59198866 |
| 112 | Insulin secretion_Homo sapiens_hsa04911 | 0.58482450 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58345341 |
| 114 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57796896 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57794135 |
| 116 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54955958 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.54556754 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53654240 |
| 119 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53636002 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53467936 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53239361 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51112006 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48719301 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48287896 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46781372 |
| 126 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45990106 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45115975 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44727478 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44639818 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43854209 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43004366 |
| 132 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40424520 |
| 133 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40190909 |
| 134 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37106683 |
| 135 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.36846786 |
| 136 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35028123 |
| 137 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.34791130 |
| 138 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33037129 |
| 139 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31445024 |
| 140 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30887446 |
| 141 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29085355 |
| 142 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.25399243 |
| 143 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21779735 |
| 144 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.21446883 |
| 145 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.20805161 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.19563179 |
| 147 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.18331829 |
| 148 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.17233954 |
| 149 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.17101878 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16471102 |
| 151 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.16176205 |
| 152 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16042520 |
| 153 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15098660 |
| 154 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.15079512 |
| 155 | Salivary secretion_Homo sapiens_hsa04970 | 0.14545866 |
| 156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.13839692 |

